AGORACOM Small-cap Investor Relations Blog

Agoracom Blog

Binovi $VISN.ca $BNVIF Closes Private Placement of $2.05 Million $EYPT $KALA $PTON

Posted by AGORACOM-JC at 6:45 PM on Tuesday, November 17th, 2020

http://www.smallcapepicenter.com/binovi%20square.png

Closed its previously announced non-brokered private placement financing for gross proceeds of $2,050,000
The Company issued a total of 16,078,431 units at $0.1275 per unit, with each unit comprised of one common share of the Company and one common share purchase warrant

TORONTO, ON and NEW YORK, NY / November 17, 2020 / Binovi Technologies Corp., (Binovi) (TSXV:VISN)(OTCQB:BNVIF), a leader in neuro-vision performance technology, is pleased to announce it has closed its previously announced non-brokered private placement financing for gross proceeds of $2,050,000 (the “Private Placement”). The Company issued a total of 16,078,431 units at $0.1275 per unit, with each unit comprised of one common share of the Company (a “Share”) and one common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder thereof to purchase one Share (each, a “Warrant Share”) at an exercise price of $0.40 per Warrant Share at any time until November 16, 2022. The warrants are subject to an acceleration clause whereby if the common share price is equal to or greater than $0.45 for a period of 5 consecutive trading days (at any time at or following the expiry of the four months resale restriction period), the Company may, by notice to the warrant holder reduce the remaining exercise period applicable to the warrants to not less than 30 days from the date of such notice.

The Company paid aggregate finder’s fees of $21,274.65 in cash and 166,860 finder’s warrants, with each finder warrant having the same terms as the Warrants.

The securities issued in connection with the Private Placement are subject to a four-month hold period expiring on March 18, 2021. Further restrictions may apply to certain subscribers under foreign securities laws.

Insiders participated in the Private Placement acquiring an aggregate of 2,284,314 units on the same basis as other subscribers. The participation in the Private Placement by insiders of the Company constitutes a “related party transaction” as such term is defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company is relying on exemptions from the formal valuation and minority approval requirements under MI 61-101. The Company relied on Section 5.5(a) of MI 61-101 for an exemption from the formal valuation requirement and Section 5.7(1)(a) of MI 61-101 for an exemption from the minority shareholder approval requirement of MI 61-101 as the fair market value of the private placement in so far as the private placement involved interested parties did not exceed 25% of the Company’s market capitalization.

The Company intends to use the net proceeds from the Private Placement for general working capital.

For additional information on the Company, please visit https://www.binovi.com/investor-reports/

About Binovi Technologies Corp.

Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 20 countries.

Terry Booth
Executive Chairman

Adam Cegielski
Founder | CEO

Investor Relations
Email: [email protected]
Toll-free: 1 (844) 866-6162

https://www.binovi.com/investor-reports/

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: Binovi Touch, CSE, Eli Wilson. Eye therapy, eye training, neuro-visual performance, tsx, tsx-v, Vision Care Specialists, vision therapy
Posted in Binovi Technologies Corp. | Comments Off on Binovi $VISN.ca $BNVIF Closes Private Placement of $2.05 Million $EYPT $KALA $PTON

CLIENT FEATURE: Kontrol Energy $KNR $KNR.ca $KNR.c $KNRLF Technology To Detect #COVID-19 In The Air $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 2:25 PM on Tuesday, November 17th, 2020

Kontrol Energy is the Google NEST of smart building technology, with a Blue Chip client base to prove it with the likes of Beyond Meat, Toyota, Oxford, Telus and Brookfield to name a few.

As a result, Kontrol is already achieving commercial success as follows:

Q1 $2.3M
Q2 $2.7M

TOTAL Q1 AND Q2

REVENUE $5M
GROSS PROFIT $2.7M

ADAPTING CORE TECH TO PROVIDE BLUE CHIP CUSTOMERS WITH REAL-TIME AIR DETECTION OF COVID-19 IN COMMERCIAL BUILDINGS

As a result of the COVID-19 pandemic and the needs of its blue chip customer base, Kontrol is adapting its core technologies team to development and commercialize its Kontrol BioCloud® analyzer, a wall-mounted technology which detects the presence of COVID-19 in the air of commercial buildings and triggers an alert system to provide real time notifications.

GEARING UP PRODUCTION FOR UP TO 20,000 UNITS PER MONTH

Initial expectations, based on lab testing completed to date, is that BioCloud will be effective in small to medium space settings with 3 or more people, and therefore would be suitable for areas such as classrooms, offices, airplanes, trains, buses, long-term care facilities and hospitals. The company is currently building a global supply chain with the goal of being able to supply 20,000 units per month.

The implications of the Kontrol BioCloud® analyzer could be enormous and could have a major impact on the global economy. Paul Ghezzi, CEO of Kontrol Energy has received calls from interested parties spanning the entire globe. In addition, mainstream media has taken notice:

Early tests suggest new Canadian technology could detect the coronavirus in the air Read More

Canadian firm develops tech to ‘detect COVID-19 in the air’; stock doubles Read More.

Kontrol Energy’s BioCloud Featured By Singapore’s IBI Times Read More

CSA APPROVAL RECEIVED ON NOVEMBER 5TH

On Novebmer 5th, KNR announced receipt of CSA standards approval for its BioCloud® technology.

“This is another important milestone for Kontrol and represents the continuing advancement of the BioCloud® technology,” says Paul Ghezzi, CEO Kontrol. “CSA is a Canadian standard for safety and is also accepted in jurisdictions outside Canada. In addition to CSA we continue to work on other important regional certifications including UL and CE for the United States and European markets respectively.”

UL STANDARDS APPROVAL RECEIVED NOVEMBER 12TH

“We continue to execute on the important milestones for commercialization of BioCloud,” says Paul Ghezzi, CEO of Kontrol. “With CSA and UL we now have standards approval that covers Canada, the United States and various other global regions. We continue to work towards CE standards certification which is primarily for the European market.”

DISCLAIMER: The Company has not made any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

For more information about the company, please check out the Kontrol Energy hub on AGORACOM.

FULL DISCLOSURE: Kontrol Energy is an advertising client of AGORA Internet Relations Corp.

Tags: BioCloud, COVID-19, CSA, CSA Standards, CSE, energy conservation, google nest, small cap, small cap stocks, stocks
Posted in All Recent Posts, Featured, Kontrol Energy Corp. | Comments Off on CLIENT FEATURE: Kontrol Energy $KNR $KNR.ca $KNR.c $KNRLF Technology To Detect #COVID-19 In The Air $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Binovi $VISN.ca $BNVIF Appoints Dr. Susan Barry to the Binovi Scientific Advisory Board $EYPT $KALA $PTON

Posted by AGORACOM-JC at 9:39 AM on Tuesday, November 17th, 2020

Announced the appointment of Dr. Susan Barry to the Binovi Scientific Advisory Board. Dr. Barry joins the other members of the board in directing the company’s advancements
“Dr. Barry’s experiences as a patient of vision therapy have informed her extensive career and we hope to gain from her perspective on both sides of the vision care coin. Her work in the neurological examination of vision will prove incredibly valuable in our pursuit of further testing and treatment options for students and patients young and old,” commented Adam Cegielski, President and CEO.

November 17, 2020 Toronto, New York – Binovi Technologies Corp., (Binovi) (TSXV:VISN ) ( OTC:BNVIF) is proud to announce the appointment of Dr. Susan Barry to the Binovi Scientific Advisory Board. Dr. Barry joins the other members of the board in directing the company’s advancements.

“Dr. Barry’s experiences as a patient of vision therapy have informed her extensive career and we hope to gain from her perspective on both sides of the vision care coin. Her work in the neurological examination of vision will prove incredibly valuable in our pursuit of further testing and treatment options for students and patients young and old,” commented Adam Cegielski, President and CEO.

“It is a distinct privilege to have Dr. Barry join our Scientific Advisory Board,” said Dr. Leonard Press, Chief Scientific Officer. “Her unique blend of insights and communication skills that crosses many lines between educators, eyecare professionals, researchers and the public is a tremendous asset to Binovi.”

” Children struggling in school, adults recovering from a stroke, and athletes seeking to improve their game may all benefit from vision therapy. Its effects are often life-changing. I am looking forward to working with the Binovi team to develop new training techniques, explore the science behind vision therapy, and make vision therapy more accessible worldwide,” commented Dr. Susan R Barry, Ph.D.

About Dr. Susan Barry

Susan R. Barry, Ph.D. is an educator, scientist, and author who has spoken worldwide on the topics of neuroplasticity and binocular vision. She earned her B.A. in biology from Wesleyan University in 1976 and Ph.D. in biology from Princeton University in 1981. She has worked as a research neuroscientist at the University of Miami Medical School, the University of Michigan, the Marine Biological Laboratory, and NASA’s Johnson Space Center and published papers on synaptic transmission and eye-head-hand coordination. In 1992, she joined the faculty of Mount Holyoke College where she rose to the rank of full professor, retiring from the college in 2016. The Princeton Review lists Barry among the 300 outstanding college teachers in the U.S., her paper on the work of Frederick W. Brock was selected as the best published paper in the Journal of Behavioral Optometry in 2011, and in 2013 she received the Meribeth E. Cameron Faculty Award for Scholarship from Mount Holyoke College.

For years, Barry taught her neurobiology students the conventional scientific wisdom that stereovision could develop only during a critical period in early childhood. She even used her own vision history to support this dogma since she had been cross-eyed since early infancy and was stereoblind. However, at age forty-eight, she consulted a developmental optometrist who prescribed a program of optometric vision therapy. To her utter astonishment, her vision improved dramatically, and she experienced her first 3D views. Dubbed “Stereo Sue” by Oliver Sacks in a 2006 New Yorker article by that name, Dr. Barry has gone on to write her own book Fixing My Gaze: A Scientist’s Journey into Seeing in Three Dimensions (Basic Books, 2009) which was rated the fourth best science book for 2009 by the editors of Amazon.com, selected as one of the best sci-tech books of 2009 by the Library Journal, and has been translated into seven languages. Barry’s second book, Coming to Our Senses: A Boy Who Learned to See, A Girl Who Learned to Hear, and How We All Discover the World , will be published by Basic Books in the summer of 2021.

For additional information on the Company, please visit https://www.binovi.com/investor-reports

About Binovi Technologies Corp.

Binovi is a best-in-class neuro-visual platform designed to test, analyze, track, and report on individual vision and cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Sports Performance testing and training, and other areas of specialized care. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 1,500 locations across 20 countries.

Terry Booth

Executive Chairman

Adam Cegielski

Founder | CEO

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

https://www.binovi.com/investor-reports/

Forward looking information:

Tags: Binovi Touch, CSE, Eli Wilson. Eye therapy, eye training, neuro-visual performance, tsx, tsx-v, Vision Care Specialists, vision therapy, vision training
Posted in Binovi Technologies Corp. | Comments Off on Binovi $VISN.ca $BNVIF Appoints Dr. Susan Barry to the Binovi Scientific Advisory Board $EYPT $KALA $PTON

Red Light Holland $TRIP.ca Engages RadixMotion to Develop iMicrodose Digital Care Program Using Latest Immersive Technology $SHRM.ca $RVV.ca $MMED $PLNT.ca

Posted by AGORACOM at 9:09 AM on Tuesday, November 17th, 2020

RadixMotion will design and develop a digital care program for people exploring microdosing
The core of the digital care program is a privacy first iMicrodose Journal,
A web app where people can anonymously document their microdosing and receive data driven analytics that will help them make informed choices around their usage

Toronto, Ontario–(Newsfile Corp. – November 17, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“) is pleased to announce that via its Scarlette Lillie Science and Innovation division, it has engaged RadixMotion Inc. (“RadixMotion“), an immersive technology company based in the State of Delaware, to design and develop a digital care program for people exploring microdosing. The program will accompany customers from the first time they encounter iMicrodose products in Smartshops via the iMicrodose Media Information Centre (“iMIC“) with an educational interactive augmented reality app. The core of the digital care program is a privacy first iMicrodose Journal, a web app where people can anonymously document their microdosing and receive data driven analytics that will help them make informed choices around their usage. The app will use Radix Motion’s expertise in biometric human pose data to give people feedback on whether microdosing has measurable effects on reducing their physiological tension or influences other features of their body posture. People using the digital care program will be able to opt in to share their anonymous data with the wider community allowing for substantial advancements in research.

“As access to psychedelics grows we want to provide people with the support they need to make the most out of microdosing via digital health mechanisms, which now includes our iMicrodose digital care program,” said Todd Shapiro, the Chief Executive Officer and Director of the Company. “While other companies in the sector are focused on clinical trials which take years to prove out, this approach of Scarlette Lillie, our science and innovation division, can have immediate benefits. We want to be a part of understanding psilocybin usage now as the mental health crisis is rampant. Gatekeepers can be limiting. We believe in working with informed consumers who are willingly sharing their data.”

‘Digital Health’ is defined as the convergence of digital technologies with health, healthcare, living, and society to enhance the efficiency of healthcare delivery and make it more personalized and precise. Scarlette Lillie is pleased to continue their partnership with Sarah Hashkes, CEO of RadixMotion – who published the first academic paper using the Predictive Coding frameworks to explain what psychedelics do to brains – to create a personalized iMicrodose Journal, a web-based app where people will be able to document their psilocybin use and they will be able to opt in to share their anonymous important data with the community which can then potentially be shared with scientific and medical experts. Microdosing research is at its infancy and this data has huge potential to increase Scarlette Lillie’s understanding rapidly.

“We are excited that our expertise in neuroscience and immersive technology is giving people tools to understand themselves and promoting responsible use of psychedelics. Red Light Holland’s and Scarlette Lillie’s care for their customers is a beacon of hope in the emerging psychedelic market. The consent based approach this program is taking around customers’ data and communicating with customers, we believe, is revolutionary and we hope many companies will follow this example. We are also excited about the AR aspect where customers can receive inspirational messages based on the latest research on wellness when they aim the app at iMicrodose products,” said Sarah Hashkes, CEO of RadixMotion and Scarlette Lillie’s Scientific Advisor. “But where it gets really exciting, as a scientific researcher in psychedelics, is if people do trust us and opt in to share their anonymous data with the community we will have a data set that can take microdosing research to a whole new level. The journal will immediately provide people with analytics about their microdosing so they can find what works best for them, but in the long run, Scarlette Lillie can hopefully use this data, including the unique biometric human pose data, to potentially find out what works best for people all over the world.”

Scarlette Lillie Science and Innovation estimates the total cost for the iMicrodose Digital Care Program, including Augmented Reality for the in-store iMic centres and the iMicrodose web-app Journal to be approximately USD$85,000. The completion of the Augmented Reality for the in-store iMIC remains on pace, expected to be launched before the end of 2020 and the iMicrodose web-app Journal is expected to be completed by RadixMotion and available by the end of Q1 2021.

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles, microdose, stocks
Posted in All Recent Posts, Red Light Holland | Comments Off on Red Light Holland $TRIP.ca Engages RadixMotion to Develop iMicrodose Digital Care Program Using Latest Immersive Technology $SHRM.ca $RVV.ca $MMED $PLNT.ca

Lomiko $LMR.ca Forms Technical, Safety, and Sustainability Committee and Charter to Oversee La Loutre Assessment $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca

Posted by AGORACOM at 9:04 AM on Tuesday, November 17th, 2020

Vancouver, B.C., Nov. 17, 2020 (GLOBE NEWSWIRE) — Lomiko Metals Inc. (“Lomiko”) (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) is focused on the exploration and development of flake graphite in Quebec for the new green economy. Lomiko is pleased to announce the Board of Directors has formed a Technical, Safety, and Sustainability Committee (“LTSSC”), reporting to the Board of Directors. At the time of formation, the LTSCC is comprised of A. Paul Gill, CEO, and two Independent Directors, Gabriel Erdelyi and Julius Galik.

LTSSC Committee Responsibilities

The LTSSC will oversee the assessment of the La Loutre Flake Graphite Property, and liaise with service providers, technical staff and stakeholders to put forward a series of crucial technical documents including, but not limited to, a Scope of Work (SOW), Graphite Characterization and Metallurgy, Response for Proposal (RFP) on a Preliminary Economic Assessment, and, if required, pre-feasibility, bulk samples, pilot plant, feasibility and construction plans. The Committee will govern the hiring of technical staff, liaise with extra-company agencies and representatives, and provide a conduit to the Board of Directors to make crucial decisions on the project.

Further additions to the Committee and the Lomiko team are anticipated and will be announced when confirmed.

Lomiko’s Near Term Goals

Graphite demand is expected to increase exponentially for the mined natural graphite material, as more is used in the production of spherical graphite for graphite in the anode portion of Electric Vehicle Lithium-ion batteries.

Lomiko completed a $ 750,000 financing October 23, 2020 and plans to work on its near-term goals:

1) Complete 100% Acquisition of the Property, currently 80% owned by Lomiko Metals.

2) Complete metallurgy and graphite characterization to confirm li-ion anode grade material.

3) Complete a Technical Report to confirm that the extent of the mineralization equals or surpasses the nearby Imerys Mine, owned by an international mining conglomerate.

A “technical report” means a report prepared and filed in accordance with this Instrument and Form 43-101F1 Technical Report, and includes, in summary form, all material scientific and technical information in respect of the subject property as of the effective date of the technical report;

4) Complete Preliminary Economic Assessment (PEA)

A PEA means a study, other than a pre-feasibility or feasibility study, that includes an economic analysis of the potential viability of mineral resources.

For more information on Lomiko Metals, Promethieus, review the website at www.lomiko.com, and www.promethieus.com, contact A. Paul Gill at 604-729-5312 or email: [email protected].

On Behalf of the Board

“A. Paul Gill”

Director, Chief Executive Officer

Tags: #Battery, #Carbon, #Demand, #Electric, #Evolution, #graphite, #Green, #High-Grade, graphite, LaLoutre
Posted in All Recent Posts, Lomiko Metals | Comments Off on Lomiko $LMR.ca Forms Technical, Safety, and Sustainability Committee and Charter to Oversee La Loutre Assessment $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca

AGORACOM Small Cap 60: Else Nutrition $BABY.ca $BABYF First Shipment to U.S. Retailers in Time for Christmas and Holiday Shopping, Including a Soon-To-Be Announced, National Major Grocery Chain $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 8:39 AM on Tuesday, November 17th, 2020

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

KeHE is one of the largest and most well regarded national fresh, natural and organic and specialty food distributors in North America. Else and KeHE have activated five distribution centers in various regions across the U.S. This distribution will enable Else’s first product to be on the shelves of numerous U.S. retail stores, including a soon-to-be announced, national major grocery chain.

Tags: Amazon, baby food, Bristol-Myers Squibb Co, ConAgra Brands, CSE, gut health, investing, organic, small cap
Posted in AGORACOM Small Cap 60, Else Nutrition Holdings Inc., Featured | Comments Off on AGORACOM Small Cap 60: Else Nutrition $BABY.ca $BABYF First Shipment to U.S. Retailers in Time for Christmas and Holiday Shopping, Including a Soon-To-Be Announced, National Major Grocery Chain $BYND $VERY.ca $INGR $VEGN $TOFB

EVENT: CSE Presents Tech Tuesdays: Israeli Technology Advancements Featuring InnoCan Pharma $INNO.ca $CGC.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 7:37 AM on Tuesday, November 17th, 2020

Don’t Miss Tech Tuesdays: Israeli Technology Advancements

The CSE looks forward to co-hosting our next Tech Tuesdays showcase, Israeli Technology Advancements, with the Canada Israel Chamber of Commerce.

Join us live on November 17th!

Check out the exciting list of featured speakers!

Elad Barkan, CTO of Cannibble FoodTech Ltd.
Anna Ettedgui, Head of Funding at Blender
Iris Bincovich, CEO of InnoCan Pharma Corp. (CSE:INNO)

Don’t miss out on this exclusive glimpse at the cutting-edge technologies hailing from Israel that are making waves internationally.

Tags: CBD Derma Cosmetics, CBD stocks, CSE, Facial Serum, Innocan, Khiron Life Sciences Corp, Ovation Science Inc., Relief & Go Pain Relief Spray, SHIR, Skin care
Posted in Innocan Pharma Corporation | Comments Off on EVENT: CSE Presents Tech Tuesdays: Israeli Technology Advancements Featuring InnoCan Pharma $INNO.ca $CGC.ca $APHA $OVAT.ca $KHRN.ca

Else Nutrition $BABY.ca $BABYF Commences First Shipment to U.S. Retailers in Time for Christmas and Holiday Shopping $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 7:28 AM on Tuesday, November 17th, 2020

Novel, Plant-based Complete Nutrition for Toddlers to hit retail shelves in coming weeks
Now commenced shipping its Plant-Based Complete Nutrition for Toddlers to retail stores across the U.S..
The Company and its distribution partner, KeHE Distributors, has thus far activated five distribution centers in various regions across the U.S.
This distribution will enable Else’s first product to very quickly be on the shelves of numerous U.S. retail stores, including a soon-to-be announced, national major grocery chain.

VANCOUVER, BC , Nov. 17, 2020 ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQB: BABYF) (FSE: 0YL) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company , is pleased to announce that as part of its mission to ensure its novel, plant-based toddler nutrition products will be accessible to health conscious families across North America , that it has now commenced shipping its Plant-Based Complete Nutrition for Toddlers to retail stores across the U.S.. The Company and its distribution partner, KeHE Distributors, has thus far activated five distribution centers in various regions across the U.S. This distribution will enable Else’s first product to very quickly be on the shelves of numerous U.S. retail stores, including a soon-to-be announced, national major grocery chain.

“We are so pleased that Else will be available to consumers on their favourite store shelves in advance of the Christmas holiday,” said Mrs. Hamutal Yitzhak , CEO and Co-Founder of Else. “We are making strong headway now, adding brick and mortar as a core sales vertical, to be complemented by our already-growing e-commerce and Amazon business verticals. We continue to extend our appreciation to KeHE Distributors for its early support of our brand, and anticipate early success and aggressive listings in 2021, as we develop our core retail accounts,” she added.

KeHE Distributors has nearly 70 years of experience servicing store owners and today has a network of over 16 distribution centers across North America . KeHE is one of the largest and most well regarded national fresh, natural and organic and specialty food distributors in North America . Else Nutrition’s agreement with KeHE Distributors secures a retail distribution path of Else’s ground-breaking plant-based toddler nutrition products to thousands of store shelves in the United States , and millions of consumers seeking plant-based alternatives for their children.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Tags: Amazon, baby food, Bristol-Myers Squibb Co, ConAgra Brands, CSE, gut health, investing, organic, small cap, stocks
Posted in All Recent Posts, Else Nutrition Holdings Inc., Featured | Comments Off on Else Nutrition $BABY.ca $BABYF Commences First Shipment to U.S. Retailers in Time for Christmas and Holiday Shopping $BYND $VERY.ca $INGR $VEGN $TOFB

AGORACOM Small Cap 60: Avicanna $AVCN.ca $AVCNF Medical #Cannabis Trusted By Physicians and Clinicians $TRUL.ca $ACB

Posted by AGORACOM-JC at 3:06 PM on Monday, November 16th, 2020

http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

Aras Azadian Chief Executive Officer and Co-Founder of Avicanna discusses the company’s medical cannabis which is trusted by physicians and clinicians. Azadian states, “Only 5% of physicians are currently prescribing Cannabis.” He continues to explain that the medical community has been skeptical of Canadian Licensed producers. Avicanna provides medical and only medical, this bodes well with the medical community.

Tags: cannabinoids, Cannabis cultivation, CBD, CSE, Marijuana, Medical Cannabis by Shoppers, Rho Phyto, stocks, Trulieve Cannabis Corp., tsx, tsx-v
Posted in AGORACOM Small Cap 60, Avicanna Inc. | Comments Off on AGORACOM Small Cap 60: Avicanna $AVCN.ca $AVCNF Medical #Cannabis Trusted By Physicians and Clinicians $TRUL.ca $ACB

A 998-Carat Diamond, the Fifth-Largest Ever, Discovered in Botswana SPONSOR: Arctic Star Exploration $ADD.ca $RIO $DIAM.ca $NAR.ca $MPVD.ca

Posted by AGORACOM at 11:49 AM on Monday, November 16th, 2020

SPONSOR: Arctic Star Exploration is currently exploiting the Diagras Diamond Property, NWT. Adjoined by both Diavik and Ekati Mines, Arctic has combined known data on Diagras with modern Gravity and EM geophysical survey techniques to delineate viable Kimberlite targets. Arctic Star is currently preparing a drill program. CLICK HERE FOR MORE INFO

Another week, another huge diamond discovered in Botswana. But “huge” might do this stone a disservice, as it’s actually one of the five largest ever unearthed.

Canadian miner Lucara Diamond Corp has just announced the recovery of a 998-carat high white diamond at its Karowe mine in the southern African nation. The diamond is clivage, meaning it will have to be broken down before it can be processed into polished stones.

Lucara found the massive stone—which measures 2.6 inches x 1.9 inches x 1.8 inches—from direct milling of ore sourced from the south lobe of the mine, according to a press release. It’s just the latest noteworthy diamond discovery at the mine this year. Just in 2020 alone, Karowe has produced 31 diamonds greater than 100 carats, of which 10 are greater than 200 carats and two are greater than 500 carats. The other 500-plus carat stone is a 549-carat diamond named Sethynya that Lucara recently sold to Louis Vuitton.

Even before these recent discoveries, Karowe already had a reputation of producing giant stones. In 2015, the company found a 1,109-carat Lesedi La Rona which sold for $53 million, and shortly after that a 813-carat Constellation stone that went for $63 million, according to Bloomberg. And last year, the Lucara found a 1,758-carat—the second biggest on the planet—which it also sold to Louis Vuitton in February of this year.

“Lucara is extremely pleased with the continued recovery of large high-quality diamonds from the South Lobe of the Karowe mine,” CEO Eira Thomas said in a statement. “To recover two 500-plus carat diamonds in 10 months along with the many other high-quality diamonds across all the size ranges is a testament to the unique aspect of the resource at Karowe and the mine’s ability to recover these large and rare diamonds.”

It remains to be seen what will happen to the diamond now. Lucara did not immediately respond to a request for comment from Robb Report, but did say in the press release that it is evaluating potential steps forward with its cutting and polishing partner, HB Antwerp.

SOURCE: https://www.yahoo.com/lifestyle/998-carat-diamond-fifth-largest-223000002.html

Tags: #ADD, ArcticStar, BuddyDoyle, Diamonds, Diavik, Discovery, Finland, Kimberlite
Posted in All Recent Posts, Arctic Star Diamonds | Comments Off on A 998-Carat Diamond, the Fifth-Largest Ever, Discovered in Botswana SPONSOR: Arctic Star Exploration $ADD.ca $RIO $DIAM.ca $NAR.ca $MPVD.ca